Heteroaryl-pyramidine derivatives as JAK inhibitors

Details for Australian Patent Application No. 2003295396 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Ledeboer, Mark; Bethiel, Randy S.

Agent Cullen & Co

Pub. Number AU-B-2003295396

PCT Number PCT/US2003/0351

PCT Pub. Number WO2004/041814

Priority 60/423,579 04.11.02 US

Filing date 4 November 2003

Wipo publication date 7 June 2004

Acceptance publication date 26 February 2009

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/423,579 04.11.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003295396

26 February 2009 Application Accepted

  Published as AU-B-2003295396

25 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003295397-CHANGEOVER VALVE AND DUAL AIR SUPPLY BREATHING APPARATUS

2003295395-COMPOSITIONS, SYSTEMS, AND METHODS FOR FOCUSING A CELLMEDIATED IMMUNE RESPONSE